Literature DB >> 17167633

Lateral orbital rim osteotomy in the treatment of certain skull base lesions.

Michael B Pritz.   

Abstract

Quantitative data from a recent human cadaveric study suggested that removal of the lateral orbital rim alone may be sufficient to reach many targets for which the orbitozygomatic craniotomy has been used. Consequently, a lateral orbital rim osteotomy was substituted for an orbitozygomatic craniotomy in seven patients with a variety of pathologies located in the anterior, middle, and interpeduncular fossae. In each case, lateral orbitotomy provided a satisfactory surgical corridor for diagnosis and treatment. Compared with the orbitozygomatic craniotomy, the lateral orbital rim osteotomy offers several advantages: technical simplicity, shorter operating time, and a low risk of postoperative malocclusion. If, however, prolonged access to a wide expanse of the anterior portion of the middle fossa and inferotemporal area is needed, an orbitozygomatic approach is a better choice.

Entities:  

Year:  2002        PMID: 17167633      PMCID: PMC1654774          DOI: 10.1055/s-2002-21567

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  19 in total

1.  Quantification of increased exposure resulting from orbital rim and orbitozygomatic osteotomy via the frontotemporal transsylvian approach.

Authors:  M S Schwartz; G J Anderson; M A Horgan; J X Kellogg; S O McMenomey; J B Delashaw
Journal:  J Neurosurg       Date:  1999-12       Impact factor: 5.115

2.  Osteoregenerative lateral suboccipital craniectomy using fibrin glue.

Authors:  Y Sawamura; S Terasaka; N Ishii; M Tada; H Abe
Journal:  Acta Neurochir (Wien)       Date:  1997       Impact factor: 2.216

3.  Orbitozygomatic temporopolar approach for a high basilar tip aneurysm associated with a short intracranial internal carotid artery: a new surgical approach.

Authors:  K Ikeda; J Yamashita; M Hashimoto; K Futami
Journal:  Neurosurgery       Date:  1991-01       Impact factor: 4.654

4.  Improved access to lesions of the central skull base by mobilization of the zygoma: experience with 54 cases.

Authors:  D Uttley; D J Archer; H T Marsh; B A Bell
Journal:  Neurosurgery       Date:  1991-01       Impact factor: 4.654

5.  Supraorbital-pterional approach to skull base lesions.

Authors:  O Al-Mefty
Journal:  Neurosurgery       Date:  1987-10       Impact factor: 4.654

6.  Fronto-temporal approach with orbito-zygomatic removal. Surgical anatomy.

Authors:  M Alaywan; M Sindou
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  Combined frontotemporal-orbitozygomatic approach for tumors of the sphenoid wing and orbit.

Authors:  M W McDermott; F A Durity; J Rootman; W B Woodhurst
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

8.  Orbitocraniobasal approach for anterior communicating artery aneurysms.

Authors:  K Fujitsu; T Kuwabara
Journal:  Neurosurgery       Date:  1986-03       Impact factor: 4.654

9.  An orbitocranial approach to complex aneurysms of the anterior circulation.

Authors:  R R Smith; O Al-Mefty; T H Middleton
Journal:  Neurosurgery       Date:  1989-03       Impact factor: 4.654

10.  A combined frontotemporal and lateral infratemporal fossa approach to the skull base.

Authors:  B Mickey; L Close; S Schaefer; D Samson
Journal:  J Neurosurg       Date:  1988-05       Impact factor: 5.115

View more
  3 in total

1.  Closure of dural defects after anterior clinoid and optic canal roof removal: technical note.

Authors:  Michael B Pritz
Journal:  Skull Base       Date:  2004-11

Review 2.  Novel Surgical Approaches to the Orbit.

Authors:  Ashley A Campbell; Seanna R Grob; Michael K Yoon
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Oct-Dec

3.  Modified Orbitozygomatic Approach without Orbital Roof Removal for Middle Fossa Lesions.

Authors:  Ramiro López-Elizalde; Edgar Robledo-Moreno; Gabriel O Shea-Cuevas; Esmeralda Matute-Villaseñor; Álvaro Campero; Marisol Godínez-Rubí
Journal:  J Korean Neurosurg Soc       Date:  2018-04-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.